News & Updates
Filter by Specialty:
Most HF patients do not undergo loop diuretic dose reduction after SGLT2i initiation
19 Dec 2023
Majority of the patients with heart failure (HF) who have initiated treatment with sodium-glucose cotransporter 2 inhibitor (SGLT2i) show no change in loop diuretic dose, reports a study.